Literature DB >> 28475006

Downregulation of miR-493 promoted melanoma proliferation by suppressing IRS4 expression.

Aili Cui1,2, Zhehu Jin1, Zhonggao Gao2, Mingji Jin2, Lianhua Zhu1, Lianhua Li1, Chenglong Jin1, Yinghua An1.   

Abstract

Accumulating evidence indicated that aberrantly expressed microRNAs play critical roles in the initiation and progression of human cancers. However, the underlying functions of miR-493 in human melanoma remains unknown. Here, our study found that miR-493 expression was downregulated in human melanoma tissues and cells. Overexpression of miR-493 suppressed cell proliferation and cell cycle in human melanoma cell line A375. IRS4 was defined as a target for downregulation by miR-493 and was confirmed by luciferase assay. We also found that knockdown of IRS4 counteracted the proliferation promotion by miR-493 inhibitor. In summary, these results demonstrated that miR-493 acts as a tumor suppressor and inhibits cell proliferation and cell cycle in human melanoma by directly targeting IRS4.

Entities:  

Keywords:  IRS4; MiR-493; cell cycle; cell proliferation; human melanoma

Mesh:

Substances:

Year:  2017        PMID: 28475006     DOI: 10.1177/1010428317701640

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  8 in total

Review 1.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

2.  Long Noncoding RNA LINC00173 Promotes the Malignancy of Melanoma by Promoting the Expression of IRS4 Through Competitive Binding to microRNA-493.

Authors:  Fan Yang; Pengzhen Lei; Weihui Zeng; Jianwu Gao; Na Wu
Journal:  Cancer Manag Res       Date:  2020-05-05       Impact factor: 3.989

Review 3.  Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine.

Authors:  Sophie L Mumford; Benjamin P Towler; Amy L Pashler; Onur Gilleard; Yella Martin; Sarah F Newbury
Journal:  Biomolecules       Date:  2018-04-26

4.  microRNA-493 inhibits tongue squamous cell carcinoma oncogenicity via directly targeting HMGA2.

Authors:  Dan Jiao; Yingying Liu; Zhen Tian
Journal:  Onco Targets Ther       Date:  2019-08-28       Impact factor: 4.147

5.  hsa_circ_0023409 Accelerates Gastric Cancer Cell Growth and Metastasis Through Regulating the IRS4/PI3K/AKT Pathway.

Authors:  Jian Li; Yongjing Yang; Dequan Xu; Ling Cao
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

6.  Long Non-Coding RNA LINC00466 Knockdown Inhibits Tongue Squamous Cell Carcinoma Malignancy by Targeting microRNA-493/HMGA2.

Authors:  Chao Hou; Yanli Dong; Bo Du
Journal:  Cancer Manag Res       Date:  2020-12-22       Impact factor: 3.989

7.  Possible Role of IRS-4 in the Origin of Multifocal Hepatocellular Carcinoma.

Authors:  Luis G Guijarro; Patricia Sanmartin-Salinas; Eva Pérez-Cuevas; M Val Toledo-Lobo; Jorge Monserrat; Sofía Zoullas; Miguel A Sáez; Miguel A Álvarez-Mon; Julia Bujan; Fernando Noguerales-Fraguas; Eduardo Arilla-Ferreiro; Melchor Álvarez-Mon; Miguel A Ortega
Journal:  Cancers (Basel)       Date:  2021-05-23       Impact factor: 6.639

8.  MicroRNA-493 is a prognostic factor in triple-negative breast cancer.

Authors:  Ling Yao; Yirong Liu; Zhigang Cao; Junjing Li; Yanni Huang; Xin Hu; Zhiming Shao
Journal:  Cancer Sci       Date:  2018-06-27       Impact factor: 6.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.